MYGN peer analysis
Myriad Genetics (MYGN) against its competitors: price, today's move, 1-year return and market value side by side.
MYGN and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BLLN BillionToOne | $113.12 | 2.42% | – | – |
| BNR Burning Rock | $10.94 | 8.96% | -12.65% | $115.38M |
| FLGT Fulgent Genetics | $19.68 | 1.60% | -14.84% | $532.97M |
| GH Guardant Health | $169.80 | -2.97% | 71.65% | $23.48B |
| IMDX Insight Molecular Diagnostics | $2.74 | -4.20% | -55.23% | – |
| NEO NeoGenomics | $17.02 | 1.13% | 74.03% | $2.18B |
| NTRA Natera | $382.14 | -1.67% | 92.78% | $56.02B |
| PSNL Personalis | $15.77 | 0.13% | 75.22% | $1.68B |
| QGEN QIAGEN | $50.68 | 0.60% | 10.95% | $10.40B |
| VCYT Veracyte | $51.52 | 2.45% | 41.34% | $4.04B |
| MYGN Myriad Genetics | $6.07 | 0.41% | -25.86% | $577.72M |
- MYGN's peers: BLLN (BillionToOne), BNR (Burning Rock), FLGT (Fulgent Genetics), GH (Guardant Health), IMDX (Insight Molecular Diagnostics), NEO (NeoGenomics), NTRA (Natera), PSNL (Personalis).
Updated 2026-11-05 12:51 UTC